Adage Capital Partners’s Syneos Health, Inc. Class A Common Stock SYNH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-275,000
Closed -$11.6M 963
2023
Q2
$11.6M Buy
+275,000
New +$11.1M 0.03% 540
2018
Q2
Sell
-99,641
Closed -$3.54M 804
2018
Q1
$3.54M Buy
+99,641
New +$3.9M 0.01% 661
2017
Q3
Sell
-300,000
Closed -$17.6M 765
2017
Q2
$17.6M Buy
300,000
+200,000
+200% +$10.4M 0.04% 438
2017
Q1
$4.58M Sell
100,000
-300,000
-75% -$14.9M 0.01% 625
2016
Q4
$21M Sell
400,000
-200,000
-33% -$9.68M 0.06% 362
2016
Q3
$26.7M Buy
600,000
+100,000
+20% +$4.34M 0.07% 332
2016
Q2
$19.1M Sell
500,000
-300,000
-38% -$13.2M 0.05% 372
2016
Q1
$33M Buy
800,000
+100,000
+14% +$4.12M 0.09% 261
2015
Q4
$34M Sell
700,000
-450,000
-39% -$20M 0.09% 262
2015
Q3
$46M Buy
1,150,000
+350,000
+44% +$15.3M 0.13% 212
2015
Q2
$32.1M Buy
800,000
+50,000
+7% +$1.73M 0.08% 310
2015
Q1
$24.5M Sell
750,000
-250,000
-25% -$6.9M 0.06% 377
2014
Q4
$25.7M Buy
+1,000,000
New +$23.8M 0.06% 353

Other funds holding SYNH

Adage Capital Partners's SYNH Position: Q3 2023 in Review

Adage Capital Partners sold out of Syneos Health, Inc. Class A Common Stock (SYNH) in Q3 2023, closing a stake of 275,000 shares — an estimated $11.6M sold.

Adage Capital Partners first reported a position in SYNH in Q4 2014 and held it in 13 quarters. The position peaked at $46M in Q3 2015. 10 funds tracked by Wall St. Rank hold SYNH as of Q3 2023.

  • Adage Capital Partners reported no remaining Syneos Health, Inc. Class A Common Stock position as of Q3 2023 after selling out during the quarter.
  • Adage Capital Partners sold 275,000 Syneos Health, Inc. Class A Common Stock shares in Q3 2023, an estimated $11.6M.
  • Adage Capital Partners first reported a position in Syneos Health, Inc. Class A Common Stock in Q4 2014 and held it in 13 quarters.
  • Adage Capital Partners's Syneos Health, Inc. Class A Common Stock position peaked at $46M in Q3 2015.
  • 10 funds tracked by Wall St. Rank held Syneos Health, Inc. Class A Common Stock as of Q3 2023.

Based on Adage Capital Partners's 13F filing for Q3 2023, filed 14 Nov 2023.